within Pharmacolibrary.Drugs.ATC.R;

model R03BA07
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0010166666666666666,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.22,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03BA07</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mometasone is a potent synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It is primarily used as a topical agent for the treatment of skin disorders, as a nasal spray for allergic rhinitis, and as an inhaled agent for asthma. It is approved for use in many countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for inhaled mometasone furoate in healthy adults due to absence of detailed published pharmacokinetic data specific to this ATC classification (R03BA07, inhaled route).</p><h4>References</h4><ol><li><p>Vaidya, S, et al., &amp; Tillmann, HC (2020). Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects. <i>Pulmonary pharmacology &amp; therapeutics</i> 64 101964–None. DOI:<a href=\"https://doi.org/10.1016/j.pupt.2020.101964\">10.1016/j.pupt.2020.101964</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33035700/\">https://pubmed.ncbi.nlm.nih.gov/33035700</a></p></li><li><p> (2020). Drugs for COPD. <i>The Medical letter on drugs and therapeutics</i> 62(1606) 137–144. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32960872/\">https://pubmed.ncbi.nlm.nih.gov/32960872</a></p></li><li><p>Vaidya, S, et al., &amp; Hosoe, M (2021). Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers. <i>Pulmonary pharmacology &amp; therapeutics</i> 70 102019–None. DOI:<a href=\"https://doi.org/10.1016/j.pupt.2021.102019\">10.1016/j.pupt.2021.102019</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33771722/\">https://pubmed.ncbi.nlm.nih.gov/33771722</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03BA07;
